Hinge Health Inc. (NYSE:HNGE - Get Free Report) shares were up 10.7% during trading on Tuesday . The stock traded as high as $48.85 and last traded at $48.37. Approximately 904,399 shares traded hands during mid-day trading, an increase of 5% from the average daily volume of 862,172 shares. The stock had previously closed at $43.69.
Analyst Upgrades and Downgrades
A number of brokerages recently commented on HNGE. Raymond James Financial assumed coverage on Hinge Health in a research note on Monday, June 16th. They issued an "outperform" rating and a $45.00 target price for the company. Evercore ISI began coverage on shares of Hinge Health in a research report on Monday, June 16th. They set an "outperform" rating and a $50.00 target price on the stock. Stifel Nicolaus initiated coverage on Hinge Health in a report on Monday, June 16th. They set a "buy" rating and a $48.00 price objective on the stock. Royal Bank Of Canada started coverage on Hinge Health in a research report on Monday, June 16th. They issued an "outperform" rating and a $45.00 price target on the stock. Finally, Wall Street Zen upgraded shares of Hinge Health to a "hold" rating in a research note on Monday, June 2nd. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $46.00.
Get Our Latest Stock Analysis on HNGE
Hinge Health Stock Performance
About Hinge Health
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
Recommended Stories
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.